Request for Covid-19 Impact Assessment of this Report
The United States Radiopharmaceuticals for Therapeutic market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Radiopharmaceuticals for Therapeutic market, reaching US$ million by the year 2028. As for the Europe Radiopharmaceuticals for Therapeutic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Radiopharmaceuticals for Therapeutic players cover Bayer, Novartis, China Isotope & Radiation, and Dongcheng, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals for Therapeutic market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Radium-223
Lutetium-177
Iodine-131
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Thyroid
Bone Metastasis
Lymphoma
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Radiopharmaceuticals for Therapeutic Market Size 2017-2028
2.1.2 Radiopharmaceuticals for Therapeutic Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Radiopharmaceuticals for Therapeutic Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Radiopharmaceuticals for Therapeutic Market Size by Type
2.3.1 Radiopharmaceuticals for Therapeutic Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Type (2017-2022)
2.4 Radiopharmaceuticals for Therapeutic Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Radiopharmaceuticals for Therapeutic Market Size by Application
2.5.1 Radiopharmaceuticals for Therapeutic Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Application (2017-2022)
3 Radiopharmaceuticals for Therapeutic Market Size by Player
3.1 Radiopharmaceuticals for Therapeutic Market Size Market Share by Players
3.1.1 Global Radiopharmaceuticals for Therapeutic Revenue by Players (2020-2022)
3.1.2 Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Players (2020-2022)
3.2 Global Radiopharmaceuticals for Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Radiopharmaceuticals for Therapeutic by Regions
4.1 Radiopharmaceuticals for Therapeutic Market Size by Regions (2017-2022)
4.2 Americas Radiopharmaceuticals for Therapeutic Market Size Growth (2017-2022)
4.3 APAC Radiopharmaceuticals for Therapeutic Market Size Growth (2017-2022)
4.4 Europe Radiopharmaceuticals for Therapeutic Market Size Growth (2017-2022)
4.5 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Growth (2017-2022)
5 Americas
5.1 Americas Radiopharmaceuticals for Therapeutic Market Size by Country (2017-2022)
5.2 Americas Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022)
5.3 Americas Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceuticals for Therapeutic Market Size by Region (2017-2022)
6.2 APAC Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022)
6.3 APAC Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Radiopharmaceuticals for Therapeutic by Country (2017-2022)
7.2 Europe Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022)
7.3 Europe Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Radiopharmaceuticals for Therapeutic by Region (2017-2022)
8.2 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022)
8.3 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Radiopharmaceuticals for Therapeutic Market Forecast
10.1 Global Radiopharmaceuticals for Therapeutic Forecast by Regions (2023-2028)
10.1.1 Global Radiopharmaceuticals for Therapeutic Forecast by Regions (2023-2028)
10.1.2 Americas Radiopharmaceuticals for Therapeutic Forecast
10.1.3 APAC Radiopharmaceuticals for Therapeutic Forecast
10.1.4 Europe Radiopharmaceuticals for Therapeutic Forecast
10.1.5 Middle East & Africa Radiopharmaceuticals for Therapeutic Forecast
10.2 Americas Radiopharmaceuticals for Therapeutic Forecast by Country (2023-2028)
10.2.1 United States Radiopharmaceuticals for Therapeutic Market Forecast
10.2.2 Canada Radiopharmaceuticals for Therapeutic Market Forecast
10.2.3 Mexico Radiopharmaceuticals for Therapeutic Market Forecast
10.2.4 Brazil Radiopharmaceuticals for Therapeutic Market Forecast
10.3 APAC Radiopharmaceuticals for Therapeutic Forecast by Region (2023-2028)
10.3.1 China Radiopharmaceuticals for Therapeutic Market Forecast
10.3.2 Japan Radiopharmaceuticals for Therapeutic Market Forecast
10.3.3 Korea Radiopharmaceuticals for Therapeutic Market Forecast
10.3.4 Southeast Asia Radiopharmaceuticals for Therapeutic Market Forecast
10.3.5 India Radiopharmaceuticals for Therapeutic Market Forecast
10.3.6 Australia Radiopharmaceuticals for Therapeutic Market Forecast
10.4 Europe Radiopharmaceuticals for Therapeutic Forecast by Country (2023-2028)
10.4.1 Germany Radiopharmaceuticals for Therapeutic Market Forecast
10.4.2 France Radiopharmaceuticals for Therapeutic Market Forecast
10.4.3 UK Radiopharmaceuticals for Therapeutic Market Forecast
10.4.4 Italy Radiopharmaceuticals for Therapeutic Market Forecast
10.4.5 Russia Radiopharmaceuticals for Therapeutic Market Forecast
10.5 Middle East & Africa Radiopharmaceuticals for Therapeutic Forecast by Region (2023-2028)
10.5.1 Egypt Radiopharmaceuticals for Therapeutic Market Forecast
10.5.2 South Africa Radiopharmaceuticals for Therapeutic Market Forecast
10.5.3 Israel Radiopharmaceuticals for Therapeutic Market Forecast
10.5.4 Turkey Radiopharmaceuticals for Therapeutic Market Forecast
10.5.5 GCC Countries Radiopharmaceuticals for Therapeutic Market Forecast
10.6 Global Radiopharmaceuticals for Therapeutic Forecast by Type (2023-2028)
10.7 Global Radiopharmaceuticals for Therapeutic Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Radiopharmaceuticals for Therapeutic Product Offered
11.1.3 Bayer Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Radiopharmaceuticals for Therapeutic Product Offered
11.2.3 Novartis Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Company Information
11.3.2 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product Offered
11.3.3 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 China Isotope & Radiation Main Business Overview
11.3.5 China Isotope & Radiation Latest Developments
11.4 Dongcheng
11.4.1 Dongcheng Company Information
11.4.2 Dongcheng Radiopharmaceuticals for Therapeutic Product Offered
11.4.3 Dongcheng Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Dongcheng Main Business Overview
11.4.5 Dongcheng Latest Developments
11.5 Q BioMed
11.5.1 Q BioMed Company Information
11.5.2 Q BioMed Radiopharmaceuticals for Therapeutic Product Offered
11.5.3 Q BioMed Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Q BioMed Main Business Overview
11.5.5 Q BioMed Latest Developments
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Information
11.6.2 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offered
11.6.3 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Curium Pharmaceuticals Main Business Overview
11.6.5 Curium Pharmaceuticals Latest Developments
11.7 Jubilant DraxImage
11.7.1 Jubilant DraxImage Company Information
11.7.2 Jubilant DraxImage Radiopharmaceuticals for Therapeutic Product Offered
11.7.3 Jubilant DraxImage Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Jubilant DraxImage Main Business Overview
11.7.5 Jubilant DraxImage Latest Developments
11.8 Lantheus
11.8.1 Lantheus Company Information
11.8.2 Lantheus Radiopharmaceuticals for Therapeutic Product Offered
11.8.3 Lantheus Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Lantheus Main Business Overview
11.8.5 Lantheus Latest Developments
11.9 Spectrum Pharmaceuticals
11.9.1 Spectrum Pharmaceuticals Company Information
11.9.2 Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offered
11.9.3 Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Spectrum Pharmaceuticals Main Business Overview
11.9.5 Spectrum Pharmaceuticals Latest Developments
11.10 Progenics Pharmaceuticals
11.10.1 Progenics Pharmaceuticals Company Information
11.10.2 Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offered
11.10.3 Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Progenics Pharmaceuticals Main Business Overview
11.10.5 Progenics Pharmaceuticals Latest Developments
11.11 International Isotopes
11.11.1 International Isotopes Company Information
11.11.2 International Isotopes Radiopharmaceuticals for Therapeutic Product Offered
11.11.3 International Isotopes Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 International Isotopes Main Business Overview
11.11.5 International Isotopes Latest Developments
12 Research Findings and Conclusion
Table 1. Radiopharmaceuticals for Therapeutic Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Radium-223
Table 3. Major Players of Lutetium-177
Table 4. Major Players of Iodine-131
Table 5. Major Players of Other
Table 6. Radiopharmaceuticals for Therapeutic Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Type (2017-2022)
Table 9. Radiopharmaceuticals for Therapeutic Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Application (2017-2022)
Table 12. Global Radiopharmaceuticals for Therapeutic Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Player (2020-2022)
Table 14. Radiopharmaceuticals for Therapeutic Key Players Head office and Products Offered
Table 15. Radiopharmaceuticals for Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Radiopharmaceuticals for Therapeutic Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Regions (2017-2022)
Table 20. Americas Radiopharmaceuticals for Therapeutic Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Radiopharmaceuticals for Therapeutic Market Size Market Share by Country (2017-2022)
Table 22. Americas Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Radiopharmaceuticals for Therapeutic Market Size Market Share by Type (2017-2022)
Table 24. Americas Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Radiopharmaceuticals for Therapeutic Market Size Market Share by Application (2017-2022)
Table 26. APAC Radiopharmaceuticals for Therapeutic Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Radiopharmaceuticals for Therapeutic Market Size Market Share by Region (2017-2022)
Table 28. APAC Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Radiopharmaceuticals for Therapeutic Market Size Market Share by Type (2017-2022)
Table 30. APAC Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Radiopharmaceuticals for Therapeutic Market Size Market Share by Application (2017-2022)
Table 32. Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Radiopharmaceuticals for Therapeutic Market Size Market Share by Country (2017-2022)
Table 34. Europe Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Radiopharmaceuticals for Therapeutic Market Size Market Share by Type (2017-2022)
Table 36. Europe Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Radiopharmaceuticals for Therapeutic Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Radiopharmaceuticals for Therapeutic
Table 45. Key Market Challenges & Risks of Radiopharmaceuticals for Therapeutic
Table 46. Key Industry Trends of Radiopharmaceuticals for Therapeutic
Table 47. Global Radiopharmaceuticals for Therapeutic Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Radiopharmaceuticals for Therapeutic Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Radiopharmaceuticals for Therapeutic Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Radiopharmaceuticals for Therapeutic Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Radiopharmaceuticals for Therapeutic Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Radiopharmaceuticals for Therapeutic Market Size Market Share Forecast by Application (2023-2028)
Table 53. Bayer Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors
Table 54. Bayer Radiopharmaceuticals for Therapeutic Product Offered
Table 55. Bayer Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Bayer Main Business
Table 57. Bayer Latest Developments
Table 58. Novartis Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors
Table 59. Novartis Radiopharmaceuticals for Therapeutic Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Novartis Latest Developments
Table 63. China Isotope & Radiation Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors
Table 64. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product Offered
Table 65. China Isotope & Radiation Main Business
Table 66. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. China Isotope & Radiation Latest Developments
Table 68. Dongcheng Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors
Table 69. Dongcheng Radiopharmaceuticals for Therapeutic Product Offered
Table 70. Dongcheng Main Business
Table 71. Dongcheng Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Dongcheng Latest Developments
Table 73. Q BioMed Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors
Table 74. Q BioMed Radiopharmaceuticals for Therapeutic Product Offered
Table 75. Q BioMed Main Business
Table 76. Q BioMed Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Q BioMed Latest Developments
Table 78. Curium Pharmaceuticals Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors
Table 79. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offered
Table 80. Curium Pharmaceuticals Main Business
Table 81. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Curium Pharmaceuticals Latest Developments
Table 83. Jubilant DraxImage Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors
Table 84. Jubilant DraxImage Radiopharmaceuticals for Therapeutic Product Offered
Table 85. Jubilant DraxImage Main Business
Table 86. Jubilant DraxImage Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Jubilant DraxImage Latest Developments
Table 88. Lantheus Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors
Table 89. Lantheus Radiopharmaceuticals for Therapeutic Product Offered
Table 90. Lantheus Main Business
Table 91. Lantheus Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Lantheus Latest Developments
Table 93. Spectrum Pharmaceuticals Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors
Table 94. Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offered
Table 95. Spectrum Pharmaceuticals Main Business
Table 96. Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Spectrum Pharmaceuticals Latest Developments
Table 98. Progenics Pharmaceuticals Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors
Table 99. Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Offered
Table 100. Progenics Pharmaceuticals Main Business
Table 101. Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Progenics Pharmaceuticals Latest Developments
Table 103. International Isotopes Details, Company Type, Radiopharmaceuticals for Therapeutic Area Served and Its Competitors
Table 104. International Isotopes Radiopharmaceuticals for Therapeutic Product Offered
Table 105. International Isotopes Radiopharmaceuticals for Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. International Isotopes Main Business
Table 107. International Isotopes Latest Developments
List of Figures
Figure 1. Radiopharmaceuticals for Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radiopharmaceuticals for Therapeutic Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Type in 2021
Figure 7. Radiopharmaceuticals for Therapeutic in Thyroid
Figure 8. Global Radiopharmaceuticals for Therapeutic Market: Thyroid (2017-2022) & ($ Millions)
Figure 9. Radiopharmaceuticals for Therapeutic in Bone Metastasis
Figure 10. Global Radiopharmaceuticals for Therapeutic Market: Bone Metastasis (2017-2022) & ($ Millions)
Figure 11. Radiopharmaceuticals for Therapeutic in Lymphoma
Figure 12. Global Radiopharmaceuticals for Therapeutic Market: Lymphoma (2017-2022) & ($ Millions)
Figure 13. Radiopharmaceuticals for Therapeutic in Other
Figure 14. Global Radiopharmaceuticals for Therapeutic Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Application in 2021
Figure 16. Global Radiopharmaceuticals for Therapeutic Revenue Market Share by Player in 2021
Figure 17. Global Radiopharmaceuticals for Therapeutic Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Radiopharmaceuticals for Therapeutic Market Size 2017-2022 ($ Millions)
Figure 19. APAC Radiopharmaceuticals for Therapeutic Market Size 2017-2022 ($ Millions)
Figure 20. Europe Radiopharmaceuticals for Therapeutic Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size 2017-2022 ($ Millions)
Figure 22. Americas Radiopharmaceuticals for Therapeutic Value Market Share by Country in 2021
Figure 23. Americas Radiopharmaceuticals for Therapeutic Consumption Market Share by Type in 2021
Figure 24. Americas Radiopharmaceuticals for Therapeutic Market Size Market Share by Application in 2021
Figure 25. United States Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Radiopharmaceuticals for Therapeutic Market Size Market Share by Region in 2021
Figure 30. APAC Radiopharmaceuticals for Therapeutic Market Size Market Share by Application in 2021
Figure 31. China Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Radiopharmaceuticals for Therapeutic Market Size Market Share by Country in 2021
Figure 38. Europe Radiopharmaceuticals for Therapeutic Market Size Market Share by Type in 2021
Figure 39. Europe Radiopharmaceuticals for Therapeutic Market Size Market Share by Application in 2021
Figure 40. Germany Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Market Share by Application in 2021
Figure 48. Egypt Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Radiopharmaceuticals for Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 54. APAC Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 55. Europe Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 57. United States Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 58. Canada Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 61. China Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 62. Japan Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 63. Korea Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 65. India Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 66. Australia Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 67. Germany Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 68. France Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 69. UK Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 70. Italy Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 71. Russia Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 72. Spain Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 75. Israel Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Radiopharmaceuticals for Therapeutic Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...